News | Press Releases

May 1, 2023

Canon Medical to Join World-Leading Course in Interventional Cardiovascular Medicine

Paris, France, May 1, 2023 – Canon Medical will join the world-leading course in interventional cardiovascular medicine, EuroPCR, from 16-19 May 2023. Visitors will get the chance to learn about the latest dose reduction tools, cutting-edge technologies that support planning and procedures, and the impact and benefits of deep learning-assisted fusion imaging.

Whether you are an interventional cardiologist, cardiac surgeon, interventional radiologist, imaging physician, nurse, or radiographer, Canon Medical offers innovative solutions that redefine intervention procedures in your daily workflows. The intelligent technologies in Interventional Cardiology elevate the ability to see more with less exposure and guide treatment options – instantly contributing to advanced decision-making. Visitors of EuroPCR will get the opportunity to hear from world-renowned key opinion leaders during the symposium Meaningful Innovations in Interventional Cardiology, held on Thursday, May 18 from 13:30 to 14:15 (Room 252A). The experts will elaborate on how they experience Canon’s solutions and technologies firsthand in their hospitals.

"Join us at the symposium to gain valuable insights into our cutting-edge solutions and technologies, as shared by Cardiologist experts," says Erwan Ladsous, European Director of Interventional X-Ray. "Visit our booth (#M47) to explore our impressive range of innovations, including advanced equipment, dedicated ultrasound and our QMAPP technology, while connecting with interventional cardiologists and specialists”.

“The integrated hemodynamic monitoring system QMAPP can easily be operated with the Alphenix tablet”, says Eric van Antwerpen, CCO of Fysicon. “The tablet reduces the need for additional personnel in the control room. Mostly used functions of QMAPP, including FFR, can be performed from the bedside, allowing you to focus on your patient.”

Learn more about Canon Medical’s participation and meaningful innovations here.